As a new procedure, the Venaseal™ by Medtronic does not currently have a procedure code and is therefore not currently covered by medicare or private medical insurance. The procedure is FDA approved and has shown great results in 4 clinical trials. Due to the procedure being new patients who want it must pay out of pocket.
The glue or chemical adhesive that Venaseal uses is a proprietary adhesive that has been used in surgical procedures for decades. The advantages of Venaseal™ is that there is no anesthesia! You are not required to wear compression before or after the procedure.
Once you have a detailed venous duplex exam Dr. Feldman will talk to you about the results and develop a treatment plan specific to your needs.
Venaseal is a great option for those who don't want to wait, have a high deductible or want to look and feel better immediately. The procedure consists of one needle stick and since there is no thermal ablation can be performed along the entire length of the vein. Patients literally can tell a difference when they walk out the door.
Not every patient is suitable for the Venaseal™ treatment. As such all patients will have to undergo our usual consultation and a venous duplex ultrasonography to find out exactly what is going on inside the legs and find out which veins are involved before a decision as to whether Venaseal™ treatment is the right choice in their legs.
The Venaseal™ treatment by Medtronic is a new way of closing the main vein in the leg that causes varicose veins (usually either the great saphenous vein GSV or the small saphenous vein SSV or both). When the Venaseal™ or “superglue” treatment is performed, only one needle hole is needed per vein treated as there is no need for the additional injections of local anaesthetic around the vein – unlike endovenous laser ablation or radiofrequency ablation.
However, although the early findings do look promising, the Venaseal™ or “superglue” treatment for varicose veins has not been around long enough to have shown that it keeps the vein is closed in the medium to long term. Clinical results show great results 18 month after clinical trials and the numbers are actually better than other treatments in some of the studies.